​At the end of April 2016, IGEA Medical held its annual national user meeting, in which over fifty surgeons, oncologists and medical professionals attended from the UK, Ireland and Europe. This meeting shared best practice, new techniques and new developments in the use of electrochemotherapy and its role as a key tool in the cancer armamentarium. We are pleased to share some of the highlights of this meeting.

 

 

The St George’s Experience of Electrochemotherapy
Joy Odili is a consultant plastic surgeon at St Georges Hospital, London. Joy discusses her role within INSP-ECT, a network that shares data, experiences, research and updates in the use of Electrochemotherapy. Her talk reviews challenging case studies including melanoma, breast and keliod cases and what to expect in the healing process. Her talk discusses the impact of Electrochemotherapy on patients quality of life and how it reduces bleeding, challenging wounds and helps patients continue with life. She summarises how the treatment has increased in popularity since the ‘NICE badge of approval’ and it is a ‘useful adjunct for treating metastases in the skin and that serious adverse effects are rare.”

 

 

Electrochemotherapy, Intra-tumoural approach
Tobian Muir is a consultant plastic surgeon at James Cook University Hospital, Middlesbrough. Tobian discusses the ESOPE recommendations and reviews the effectiveness of Intra-tumoural verses Intravenous administration of the Bleomycin in electrochemotherapy and which patients might benefits from both methods. He also discusses his use of ultrasound in reviewing subcutaneous tumours. Please note that some of the images have been blanked out due to no patient consent.

 

 

Anaesthetic guidance
Dr Gareth Kessell is a consultant anaesthetist based at James Cook Hospital, Middlesbrough. They have been providing an electrochemotherapy service for nine years and he shares what he has learnt about the procedure from an anaesthesia perspective. His talk discusses how to overcome toxicity challenges of bleomycin and electrical discharge. He also reviews peri-procedural pain management and new possibilities in the area for pain management.

 

 

Post-operative wound management
Carol Cuthbert is a clinical nurse specialist based at St George’s Hospital, London. Carol discusses the vital role of the CNS in pre-operative and post-operative care following electrochemotherapy. She emphasises how electrochemotherapy has been used to effectively treat many patients with malignant wounds and discusses the challenges of these wounds. Carol concludes that more palliative patients could benefit from an improvement in quality of life from the electrochemotherapy treatment.

 

 

Prospective Randomised Control Trial comparing Electrochemotherapy & Surgery for the Primary Treatment of Basal Cell Carcinoma; 3 Year Update
Dr Declan Soden is the Research Director at Cork Cancer Research Centre, University College Cork, Ireland. Declan provides an update about the prospective randomised control trial comparing electrochemotherapy and surgery for the primary treatment of basal cell carcinoma.

 

 

Update of standard operating procedures ESOPE II
Ms Joy Odili is a consultant plastic surgeon at St Georges Hospital, London. Joy provides an update of the standard operating procedures as detailed in ESOPE II. Her talk centres around changes that have been made to electrochemotherapy guidelines after ten years of clinical practice and experience. These guidelines included giving Bleomycin as a fast infusion rather than as a bolus, the advice that electrochemotherapy is safe with pacemakers and that electrochemotherapy can be used in conjunction with other chemotherapy treatments.

The contents of this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice because of something you have read on this website.
This website does not recommend or endorse any specific tests, physicians, medical products, procedures, opinions, or other information that may be mentioned on the Site.
The site and its contents are provided on an "as is" basis by the public communication department of IGEA S.p.A.

IGEA © 2019